Cargando…

Interstitial Brachytherapy for Orbital Sebaceous Carcinoma

Sebaceous carcinoma is characterized by its aggressive local tumor behavior and ability to metastasize. Small periocular sebaceous carcinoma are typically treated by excision with cryotherapy. Larger tumors often require adjuvant external beam radiotherapy (EBRT) and/or exenteration surgery. When us...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Feng, Stewart, Robert D., Finger, Paul T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565506/
https://www.ncbi.nlm.nih.gov/pubmed/34314398
http://dx.doi.org/10.1097/IOP.0000000000002031
_version_ 1784593832693727232
author Li, Feng
Stewart, Robert D.
Finger, Paul T.
author_facet Li, Feng
Stewart, Robert D.
Finger, Paul T.
author_sort Li, Feng
collection PubMed
description Sebaceous carcinoma is characterized by its aggressive local tumor behavior and ability to metastasize. Small periocular sebaceous carcinoma are typically treated by excision with cryotherapy. Larger tumors often require adjuvant external beam radiotherapy (EBRT) and/or exenteration surgery. When used alone, EBRT techniques typically exceed the tolerance of critical normal ocular structures. The interstitial orbital brachytherapy-boost technique permits dose escalation to the tumor bed, while minimizing radiation dose to critical normal ocular structures. Here, we present a case of orbital sebaceous carcinoma treated with excision, cryotherapy, and super-thick amniotic membrane fornix reconstruction. Then, after 3 weeks of healing, adjuvant-combined electron interstitial high-dose rate brachytherapy-boost was added to electron-beam radiotherapy to optimize the orbital radiation dose distribution, increase dose to inferonasal orbit, and allow relative sparing of orbital tissues. At 1-year follow-up, there was no evidence of orbital tumor, no significant eye lash loss, normal ocular motility, no radiation retinopathy, optic neuropathy and a visual acuity of 20/20.
format Online
Article
Text
id pubmed-8565506
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-85655062021-11-05 Interstitial Brachytherapy for Orbital Sebaceous Carcinoma Li, Feng Stewart, Robert D. Finger, Paul T. Ophthalmic Plast Reconstr Surg Case Reports Sebaceous carcinoma is characterized by its aggressive local tumor behavior and ability to metastasize. Small periocular sebaceous carcinoma are typically treated by excision with cryotherapy. Larger tumors often require adjuvant external beam radiotherapy (EBRT) and/or exenteration surgery. When used alone, EBRT techniques typically exceed the tolerance of critical normal ocular structures. The interstitial orbital brachytherapy-boost technique permits dose escalation to the tumor bed, while minimizing radiation dose to critical normal ocular structures. Here, we present a case of orbital sebaceous carcinoma treated with excision, cryotherapy, and super-thick amniotic membrane fornix reconstruction. Then, after 3 weeks of healing, adjuvant-combined electron interstitial high-dose rate brachytherapy-boost was added to electron-beam radiotherapy to optimize the orbital radiation dose distribution, increase dose to inferonasal orbit, and allow relative sparing of orbital tissues. At 1-year follow-up, there was no evidence of orbital tumor, no significant eye lash loss, normal ocular motility, no radiation retinopathy, optic neuropathy and a visual acuity of 20/20. Lippincott Williams & Wilkins 2021-07-27 2021 /pmc/articles/PMC8565506/ /pubmed/34314398 http://dx.doi.org/10.1097/IOP.0000000000002031 Text en Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Society of Ophthalmic Plastic and Reconstructive Surgery, Inc. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Case Reports
Li, Feng
Stewart, Robert D.
Finger, Paul T.
Interstitial Brachytherapy for Orbital Sebaceous Carcinoma
title Interstitial Brachytherapy for Orbital Sebaceous Carcinoma
title_full Interstitial Brachytherapy for Orbital Sebaceous Carcinoma
title_fullStr Interstitial Brachytherapy for Orbital Sebaceous Carcinoma
title_full_unstemmed Interstitial Brachytherapy for Orbital Sebaceous Carcinoma
title_short Interstitial Brachytherapy for Orbital Sebaceous Carcinoma
title_sort interstitial brachytherapy for orbital sebaceous carcinoma
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565506/
https://www.ncbi.nlm.nih.gov/pubmed/34314398
http://dx.doi.org/10.1097/IOP.0000000000002031
work_keys_str_mv AT lifeng interstitialbrachytherapyfororbitalsebaceouscarcinoma
AT stewartrobertd interstitialbrachytherapyfororbitalsebaceouscarcinoma
AT fingerpault interstitialbrachytherapyfororbitalsebaceouscarcinoma